Observational studyHepatology international2018
Sofosbuvir plus Daclatasvir with or without ribavirin for treatment of chronic HCV genotype 4 patients: real-life experience.
G Shiha et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papertrialcites it